Attend a free virtual presentation on Lobular Breast Cancer
Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine.
Read Article
Next generation therapy for men with mCRPC may extend survival
A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.
Read Article
Behind the science: Celebrating our cancer research administrator
Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.
Read Article
Charting new paths in treating ovarian cancer and recurring SCLC
Two new trials evaluating new medications or combinations of medications for people with ovarian cancer or small cell lung cancer open at Providence Cancer Institute.
Read Article
Celebrating 150 years at Providence St. Vincent Medical Center
In July 2025, Providence had the honor of celebrating the 150th anniversary of Providence St. Vincent, Oregon’s first hospital.
Read Article
Closure of Providence Seaside Inpatient Obstetric and Newborn Care Services
After careful consideration, we have made the difficult decision to close our inpatient obstetric and newborn care services at Providence Seaside Hospital.
Read Article
The future of surgery is robotic, and it’s here
Robotic thoracic surgery is less invasive, allowing patients to recover more quickly. A Providence Cancer Institute surgeon calls it a game-changer.
Read Article
A message from Jennifer Burrows, chief executive, Providence Oregon
Update from Oregon Chief Executive Jennifer Burrows: Learn about the most recent financial sustainability measures for Oregon.
Read Article
Meet the 2025 cancer research interns
Hands-on experience in a laboratory at Providence Cancer Institute helps undergraduate students find their career path in biomedical fields.
Read Article
Watch: Virtual health talk on understanding lung cancer
Learn key facts about lung cancer at a free virtual talk hosted by Providence Cancer Institute and Asian Cancer Resource & Support Services.
Read Article
A new cancer therapy at Providence helps immune cells stand their ground
A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.
Read Article
A new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer
A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.
Read Article
New Study: Providence whole genome sequencing program shows transformative potential for population health
Published in Nature NPJ Genomic Medicine, Providence-led Geno4ME research program study highlights early detection, personalized prevention and prospect of improved care outcomes.
Read Article
Cancer patients in Newberg receive a gift of comfort
A generous gift of plush blankets helps comfort patients during their chemotherapy treatments at Providence Cancer Institute Newberg Clinic.
Read Article
How cold cap therapy prevented patient’s hair loss during cancer treatment
What surprised Molly most about cold cap therapy is that she didn’t lose her hair during treatment for breast cancer.
Read Article
Oncology Lecture Series: Hereditary Hemochromatosis with Christine Johnson, M.D.
Providence Cancer Institute hematology expert to discuss the latest updates and research on hereditary hemochromatosis in live event.
Read Article
New Horizons in Immunotherapy for Cancer symposium: Collaborative cancer research
Expert voices in immuno-oncology from inside and outside Providence gather for a day of thought-provoking discussion, discovery and collaboration.
Read Article
Providence researchers share cancer discoveries at 2025 ASCO meeting
Explore new findings in cancer immunotherapy and clinical research from Providence at ASCO 2025.
Read Article
Personalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence
Providence Cancer Institute is enrolling patients for two new immunotherapy trials targeting muscle-invasive urothelial cancer and advanced solid tumors.
Read Article
Clinical trials matter, just ask Randy
When Randy was diagnosed with small cell lung cancer, he thought it was time to get his affairs in order. But a phase I clinical trial at Providence Cancer Institute gave him more time and hope.
Read Article